nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupivacaine—Stiffness—Hydrochlorothiazide—nephrolithiasis	0.0425	0.0591	CcSEcCtD
Bupivacaine—CYP2C19—urine—nephrolithiasis	0.041	0.146	CbGeAlD
Bupivacaine—PTGER1—renal system—nephrolithiasis	0.0352	0.125	CbGeAlD
Bupivacaine—PTGER1—kidney—nephrolithiasis	0.034	0.121	CbGeAlD
Bupivacaine—Trauma—Hydrochlorothiazide—nephrolithiasis	0.0339	0.0472	CcSEcCtD
Bupivacaine—CYP1A2—urine—nephrolithiasis	0.0335	0.119	CbGeAlD
Bupivacaine—Sinus bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0329	0.0458	CcSEcCtD
Bupivacaine—CYP3A4—urine—nephrolithiasis	0.0242	0.0861	CbGeAlD
Bupivacaine—CYP2D6—urine—nephrolithiasis	0.0238	0.0847	CbGeAlD
Bupivacaine—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0218	0.0304	CcSEcCtD
Bupivacaine—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0211	0.0293	CcSEcCtD
Bupivacaine—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.0206	0.0286	CcSEcCtD
Bupivacaine—SCN4A—renal system—nephrolithiasis	0.0201	0.0713	CbGeAlD
Bupivacaine—Numbness—Hydrochlorothiazide—nephrolithiasis	0.0195	0.0271	CcSEcCtD
Bupivacaine—SCN4A—kidney—nephrolithiasis	0.0194	0.0689	CbGeAlD
Bupivacaine—SCN10A—nephron tubule—nephrolithiasis	0.0188	0.0669	CbGeAlD
Bupivacaine—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.0186	0.0259	CcSEcCtD
Bupivacaine—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.018	0.025	CcSEcCtD
Bupivacaine—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0161	0.0225	CcSEcCtD
Bupivacaine—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.0159	0.0221	CcSEcCtD
Bupivacaine—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.0144	0.02	CcSEcCtD
Bupivacaine—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0182	CcSEcCtD
Bupivacaine—Injury—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0177	CcSEcCtD
Bupivacaine—Purpura—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0169	CcSEcCtD
Bupivacaine—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.011	0.0153	CcSEcCtD
Bupivacaine—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0149	CcSEcCtD
Bupivacaine—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0147	CcSEcCtD
Bupivacaine—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0144	CcSEcCtD
Bupivacaine—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0144	CcSEcCtD
Bupivacaine—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0142	CcSEcCtD
Bupivacaine—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0141	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00886	0.0123	CcSEcCtD
Bupivacaine—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00878	0.0122	CcSEcCtD
Bupivacaine—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00866	0.0121	CcSEcCtD
Bupivacaine—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00861	0.012	CcSEcCtD
Bupivacaine—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00826	0.0115	CcSEcCtD
Bupivacaine—CYP1A2—renal system—nephrolithiasis	0.00819	0.0291	CbGeAlD
Bupivacaine—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00807	0.0112	CcSEcCtD
Bupivacaine—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00799	0.0111	CcSEcCtD
Bupivacaine—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00756	0.0105	CcSEcCtD
Bupivacaine—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00753	0.0105	CcSEcCtD
Bupivacaine—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00724	0.0101	CcSEcCtD
Bupivacaine—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00706	0.00982	CcSEcCtD
Bupivacaine—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00696	0.00968	CcSEcCtD
Bupivacaine—Tension—Hydrochlorothiazide—nephrolithiasis	0.00693	0.00964	CcSEcCtD
Bupivacaine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00686	0.00954	CcSEcCtD
Bupivacaine—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00683	0.0095	CcSEcCtD
Bupivacaine—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00679	0.00944	CcSEcCtD
Bupivacaine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00665	0.00926	CcSEcCtD
Bupivacaine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00661	0.0092	CcSEcCtD
Bupivacaine—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00652	0.00908	CcSEcCtD
Bupivacaine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00649	0.00903	CcSEcCtD
Bupivacaine—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00645	0.00898	CcSEcCtD
Bupivacaine—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00633	0.00881	CcSEcCtD
Bupivacaine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00624	0.00868	CcSEcCtD
Bupivacaine—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.0062	0.00863	CcSEcCtD
Bupivacaine—Cough—Hydrochlorothiazide—nephrolithiasis	0.00616	0.00857	CcSEcCtD
Bupivacaine—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00601	0.00836	CcSEcCtD
Bupivacaine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00599	0.00833	CcSEcCtD
Bupivacaine—CYP3A4—renal system—nephrolithiasis	0.00593	0.0211	CbGeAlD
Bupivacaine—CYP2D6—renal system—nephrolithiasis	0.00583	0.0207	CbGeAlD
Bupivacaine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00581	0.00808	CcSEcCtD
Bupivacaine—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00576	0.00802	CcSEcCtD
Bupivacaine—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00576	0.00802	CcSEcCtD
Bupivacaine—CYP3A4—kidney—nephrolithiasis	0.00573	0.0204	CbGeAlD
Bupivacaine—Shock—Hydrochlorothiazide—nephrolithiasis	0.00567	0.00789	CcSEcCtD
Bupivacaine—CYP2D6—kidney—nephrolithiasis	0.00564	0.02	CbGeAlD
Bupivacaine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00562	0.00782	CcSEcCtD
Bupivacaine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00557	0.00775	CcSEcCtD
Bupivacaine—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00538	0.00749	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00525	0.0073	CcSEcCtD
Bupivacaine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00521	0.00725	CcSEcCtD
Bupivacaine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00517	0.0072	CcSEcCtD
Bupivacaine—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00514	0.00715	CcSEcCtD
Bupivacaine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00512	0.00713	CcSEcCtD
Bupivacaine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00507	0.00706	CcSEcCtD
Bupivacaine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00501	0.00697	CcSEcCtD
Bupivacaine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00493	0.00686	CcSEcCtD
Bupivacaine—Pain—Hydrochlorothiazide—nephrolithiasis	0.00493	0.00686	CcSEcCtD
Bupivacaine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00475	0.00661	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00471	0.00656	CcSEcCtD
Bupivacaine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00458	0.00637	CcSEcCtD
Bupivacaine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00455	0.00634	CcSEcCtD
Bupivacaine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00455	0.00634	CcSEcCtD
Bupivacaine—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00424	0.00591	CcSEcCtD
Bupivacaine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00413	0.00575	CcSEcCtD
Bupivacaine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00408	0.00567	CcSEcCtD
Bupivacaine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00394	0.00549	CcSEcCtD
Bupivacaine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00381	0.0053	CcSEcCtD
Bupivacaine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00366	0.0051	CcSEcCtD
Bupivacaine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00361	0.00502	CcSEcCtD
Bupivacaine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00342	0.00476	CcSEcCtD
